To the central content area
Securities firms reward program (until 2021/12/31) Bond ETFs Investors Reward Program (2021 H2) (until 2021/12/31) ETN Investors Reward Program (2021 H2) (until 2021/12/31) 2021 Education Saminars (until 2021/11/18)
:::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

3205 SLS
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Chen Le-Wei Waiting Norris Chen 02-26557166 10F-6, No.3, Park St.,Nangang District, Taipei City, Taiwan 2005/09/12
Industry Main Business
Biotechnology and Medical Care The mission of SLSC is to develop safe, effective, controllable and consistent Chinese herbal formulas that are effective, proven and affordable for the masses that are in need of them. By addressing a variety of degenerative diseases and combining state of the art Western technology with the wisdom and knowledge of Traditional Chinese Medicine, (TCM) we formulate remedies that can contribute to and make a positive difference in the health care of society at large.
 
Market Information ( 2021/09/23 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
25.595 26.05  25.85  26.05  0.10  30 0.07 1,189 0
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2021/09/23)
TPEx measures
adopted
(2021/09/23)
With warrants Can be shorted or margined? Detail
Normal N N N N Y Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
* Auditor's report on latest financial statements: auditor's report:
* More detail:MOPS
* Foreign issuers’ information is disclosed in consolidated statements.